Hansoh Pharmaceutical Group Company Limited (3692.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
As of 02:51PM HKT. Market open.
| Previous close | 16.480 |
| Open | 16.480 |
| Bid | 16.180 x N/A |
| Ask | 16.220 x N/A |
| Day's range | 15.980 - 16.580 |
| 52-week range | 9.410 - 18.760 |
| Volume | |
| Avg. volume | 4,750,049 |
| Market cap | 96.187B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 28.96 |
| EPS (TTM) | 0.560 |
| Earnings date | 29 Aug 2024 - 02 Sept 2024 |
| Forward dividend & yield | 0.21 (1.29%) |
| Ex-dividend date | 19 Jun 2024 |
| 1y target est | 19.04 |
GlobeNewswireSCYNEXIS and Hansoh Pharma Announce NMPA Acceptance of the New Drug Application for Ibrexafungerp in China
JERSEY CITY, N.J., July 20, 2023 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that China’s National Medical Products Administration (NMPA) has accepted for review a New Drug Application (NDA) for oral ibrexafungerp tablets for the treatment of adult and post-menarchal pediatric females with vulvovaginal candidiasis (VVC) in the Chinese mainland.
© 2024 Yahoo. All rights reserved.